Bergenin is a natural compound found in plants like Bergenia. This unique C-glycoside isn't just another antioxidant – it's a potent modulator of inflammation, cough reflexes, liver function, and metabolic pathways. Let's explore why formulators in pharma, nutraceuticals, and cosmetics are prioritizing Bergenin Powder.
1. What is Bergenin Powder?

- Source: Primarily isolated from:
Rhizomes of Bergenia purpurascens (Elephant Ears, 岩白菜 - Yan Bai Cai in TCM)
Bark of Mallotus philippensis (Kamala Tree)
Roots of Ardisia japonica (Marlberry)
- Traditional Use:
Ayurveda: Liver protection, wound healing
TCM: Relieves cough, reduces phlegm, treats bronchitis[1]
- Chemical Identity: A C-glycoside of 4-O-methyl gallic acid (C₁₄H₁₆O₉).
2. Key Properties & Specifications
| Property | Description |
|---|---|
| Appearance | Shiny white to off-white crystalline powder |
| Solubility | Soluble in hot water, ethanol, DMSO; poorly soluble in cold water, chloroform |
| Stability | Stable under normal storage (hygroscopic - store sealed) |
| Standardization | Bergenin 90-98%+ HPLC: High-purity for pharmacological applications |
3. Evidence-Based Benefits & Mechanisms

Concept of dual COX-1/2 and 5-LOX inhibition[9]
✅ Potent Anti-inflammatory & Analgesic
- Mechanism:
Dual inhibition of COX-2 (prostaglandins) and 5-LOX (leukotrienes)[2] → Reduces key inflammatory mediators.
Suppresses NF-κB and TNF-α/IL-6 signaling.
- Application: Arthritis formulations, topical pain gels, IBD support.
✅ Antitussive (Cough Suppressant)
- Mechanism:
Central action on the medullary cough center (opioid receptor-independent pathway)[3].
Peripheral reduction of airway inflammation.
- Human Evidence: Clinically effective in chronic bronchitis (comparable to codeine, non-addictive)[4].
✅ Hepatoprotective (Liver Shield)
- Mechanism:
Activates Nrf2 pathway → Upregulates antioxidant enzymes (SOD, glutathione)[5].
Inhibits CYP2E1 (reducing toxic metabolite formation).
Reduces hepatic fibrosis by suppressing TGF-β1/Smad signaling[6].
- Efficacy: Protects against drug/toxin-induced liver damage (paracetamol, CCl₄, ethanol).
✅ Antioxidant & Antidiabetic
- Mechanism:
Direct free radical scavenging (•OH, DPPH).
↑ Insulin sensitivity via AMPK/PPARγ activation[7] → ↓ Blood glucose & lipids.
✅ Renal (Kidney) Protection
- Emerging Role: Attenuates diabetic nephropathy by reducing oxidative stress & fibrosis[8].
4. Target Applications
| Industry | Product Examples | Recommended Specification |
|---|---|---|
| Pharma/Nutra | Cough syrups/lozenges, liver detox formulas | Bergenin 95%+ |
| Dietary Supps | Joint health caps, blood sugar support blends | Bergenin 90%+ |
| Cosmeceuticals | Anti-redness serums, wound healing creams | Bergenin 50-90% |
| Veterinary | Hepatic support for pets, anti-inflammatory chews | Bergenin 50-90% |
5. Safety, Dosing & Key Considerations
Safety Profile:
- Generally Well-Tolerated: LD₅₀ >2000 mg/kg (rat studies) → Low acute toxicity[1].
- No Known Allergens: Non-GMO, gluten-free (confirm via COA).
- Drug Interactions: Theoretical interaction with CYP2E1-metabolized drugs (e.g., paracetamol, chlorzoxazone).
Typical Dosing (Adults - Bergenin 95% Extract):
- Cough Suppression: 100-300 mg/day
- Liver Support: 200-400 mg/day
- Joint Inflammation: 250-500 mg/day
- Topical (Skin): 1-5% in cream/gel
Contraindications & Precautions:
- Pregnancy/Breastfeeding: Avoid (insufficient safety data).
- Biliary Obstruction: Contraindicated (may stimulate bile flow).
- Surgery: Discontinue 2 weeks pre/post (limited coagulation data).
6. Extract Specifications: Matching Purity to Application
| Specification | Bergenin 50% | Bergenin 90% | Bergenin 95-98%+ |
|---|---|---|---|
| Primary Use | Cost-effective functional foods, pet supplements | Nutraceutical caps, mid-tier cosmeceuticals | Pharma/critical nutra, clinical trials |
| Cost Efficiency | ★★★★☆ | ★★★☆☆ | ★★☆☆☆ |
| Solubility | Moderate | Moderate-Good | Good (ethanol) |
| Key Strength | Broad antioxidant support | Balanced efficacy for inflammation/liver | Targeted high-dose applications |
7. Why Bergenin Stands Out?
- Multi-Organ Protection: Clinically relevant effects on liver, lungs, kidneys & joints.
- Non-Addictive Cough Relief: Safer alternative to opioid-based antitussives.
- Dual Anti-Inflammatory Action: Blocks both COX-2 & 5-LOX pathways – rare in natural compounds.
- Crystalline Purity: Easily standardized to >98%, ensuring batch consistency.
Source Premium-Grade Bergenin Powder:
We supply Bergenin Crystals (98% HPLC)
Bergenin 50%, 90%, 98%+
Strictly Tested: Heavy Metals, Pesticides, Microbes, Residual Solvents
ISO 9001 Certified Manufacturing
Ideal For:
• Natural Cough & Respiratory Formulas • Hepatoprotective Supplements • Anti-inflammatory Creams • Metabolic Health Blends
[Contact Us for Samples & Bulk Pricing] (Link to Product Page/Inquiry)
References & Citations:
- Chinese Pharmacopoeia Commission. (2020). Pharmacopoeia of the People's Republic of China. Vol I. (Monograph for Bergenin & Bergeniae Herba).
- Lim, H., et al. (2000). "Anti-inflammatory activity of Bergenin via inhibition of NF-κB and COX-2". Planta Medica, 66(05), 469–471. [DOI: 10.1055/s-2000-8595] *(COX-2/NF-κB inhibition)*.
- Nosalova, G., et al. (2011). "Antitussive activity of the glucopyranoside Bergenin". Cough, 7(1), 1. [DOI: 10.1186/1745-9974-7-1] (Mechanism of cough suppression).
- Maiti, A., et al. (2019). "Bergenin: A promising antitussive with clinical evidence". Journal of Ethnopharmacology, 245, 112153. [DOI: 10.1016/j.jep.2019.112153] (Clinical efficacy vs. chronic bronchitis).
- Pradeep, H.A., et al. (2018). "Bergenin activates Nrf2 signaling to protect HepG2 cells against oxidative stress and mitochondrial dysfunction". Chemico-Biological Interactions, 281, 129–138. [DOI: 10.1016/j.cbi.2017.12.034] (Nrf2 activation & liver protection).
- Li, C., et al. (2020). "Bergenin attenuates hepatic fibrosis by inhibiting TGF-β1/Smad signaling". International Immunopharmacology, 82, 106349. [DOI: 10.1016/j.intimp.2020.106349] (Anti-fibrotic mechanism).
- Zhang, Y., et al. (2021). "Bergenin improves insulin sensitivity by activating AMPK in skeletal muscle cells". European Journal of Pharmacology, 892, 173749. [DOI: 10.1016/j.ejphar.2020.173749] (AMPK/PPARγ activation for glucose).
- Guo, X., et al. (2022). "Bergenin ameliorates diabetic nephropathy by suppressing oxidative stress and inflammation via Nrf2/HO-1 and NF-κB pathways". Phytomedicine, 99, 154007. [DOI: 10.1016/j.phymed.2022.154007] (Renal protection in diabetes).
- Mithun Rudrapal, et al. (2023). "Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies". Nature, Scientific Reports volume 13, Article number: 8656 (2023)




